Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.32 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL79020 | 0.85 | ALDH1A1 (0.35) | CYP2A6ALOX12ALDH1A1HSD17B10TSHR | |
| SCHEMBL3562666 | 0.85 | — | — | |
| SCHEMBL3149589 | 0.82 | ALDH1A1 (0.38) | ALDH1A1HSD17B10TDP1CYP1A2CYP1B1 | |
| SCHEMBL7789583 | 0.80 | CYP2A6 (0.33) | CYP2A6HSD17B10TSHRTDP1CYP1A2 | |
| SCHEMBL1719526 | 0.80 | GSTP1 (0.44) | ALDH1A1HSD17B10CYP1A2HPGDCYP1B1 | |
| SCHEMBL4720684 | 0.80 | KDM4E (0.37) | ALDH1A1TSHRTDP1CYP1A2CYP3A4 | |
| SCHEMBL6929494 | 0.80 | — | — | |
| SCHEMBL9418157 | 0.79 | ESR1 (0.47) | ALDH1A1HSD17B10CYP1A2HPGD | |
| SCHEMBL7139286 | 0.79 | ALDH1A1 (0.41) | CYP2A6ALDH1A1TDP1CYP1A2CYP1B1 | |
| SCHEMBL3249728 | 0.79 | ALDH1A1 (0.34) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117263824-A | Synthesis process of pregabalin chiral intermediate | 江苏阿尔法药业股份有限公司 | 2023-12-22 | — | — | CN | claimed |
| EP-2970807-A1 | METHOD FOR IMPROVING THERMAL -OXIDATIVE STABILITY AND ELASTOMER COMPATIBILITY | ExxonMobil Research and Engineering Company (US) | 2016-01-20 | — | — | EP | claimed |
| US-9062269-B2 | Method for improving thermal-oxidative stability and elastomer compatibility | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-06-23 | — | — | US | claimed |
| WO-2014149406-A1 | METHOD FOR IMPROVING THERMAL -OXIDATIVE STABILITY AND ELASTOMER COMPATIBILITY | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2014-09-25 | — | — | WO | claimed |
| US-20140274836-A1 | METHOD FOR IMPROVING THERMAL-OXIDATIVE STABILITY AND ELASTOMER COMPATIBILITY | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2014-09-18 | — | — | US | claimed |
| US-7049453-B2 | “Constrained geometry” metallocenes, method for the production thereof and use of the same for the polymerisation of olefins | CELANESE VENTURES GMBH (DE) | 2006-05-23 | — | — | US | claimed |
| EP-1089818-B1 | CATALYST COMPRISING A COMPLEX OF A METAL OF GROUP VIII AND A PHOSPHINITE LIGAND, AND A METHOD FOR HYDROFORMYLATION | BASF AG (DE) | 2005-04-06 | — | — | EP | claimed |
| CN-117776830-A | Full deuteration preparation method of polycyclic aromatic hydrocarbon | 宁波萃英化学技术有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117263824-A | Synthesis process of pregabalin chiral intermediate | 江苏阿尔法药业股份有限公司 | 2023-12-22 | — | — | CN | disclosed |
| WO-2023054417-A1 | LITHIUM SALT EXTRACTION AGENT, COMPOSITION, LITHIUM SALT RECOVERY METHOD, AND LITHIUM SALT PRODUCTION METHOD | 株式会社レゾナック | 2023-04-06 | — | — | WO | disclosed |
| US-20230037858-A1 | COMPOSITION CONTAINING ADDITION CONDENSATION PRODUCT, METHOD FOR PRODUCING SAME, USE OF SAME, POLYMERIZATION VESSEL, AND METHOD FOR PRODUCING POLYMER | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-02-09 | — | — | US | disclosed |
| WO-2023277164-A1 | ADDITIVE FOR ELECTROLYTE SOLUTIONS, ELECTROLYTE SOLUTION AND ELECTROCHEMICAL DEVICE | 昭和電工マテリアルズ株式会社 | 2023-01-05 | — | — | WO | disclosed |
| US-11345651-B2 | Addition condensation product, production method and use of same, polymerization vessel, and production method of polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-05-31 | — | — | US | disclosed |
| US-4329254-A | CHROMATOGRAPHY | CHMIELOWIEC JAN | 1982-05-11 | — | — | US | disclosed |
| US-4229274-A | PHOTOINITIATOR, PHOTOSENSITIZER, QUENCHER, AND COMPOUNDS CONTAINING ACRYLYLOXY GROUPS | PPG INDUSTRIES, INC. (US) | 1980-10-21 | — | — | US | disclosed |
| US-4026861-A | AROMATIZATION CATALYST | HERCULES INCORPORATED (US) | 1977-05-31 | — | — | US | disclosed |
| US-4026859-A | AROMATIZATION CATALYST | HERCULES INCORPORATED (US) | 1977-05-31 | — | — | US | disclosed |
| US-4026860-A | AROMATIZATION CATALYST | HERCULES INCORPORATED (US) | 1977-05-31 | — | — | US | disclosed |
| US-4020073-A | Process for O-acylating thallus salts of 2-pyridone | TAYLOR EDWARD C | 1977-04-26 | — | — | US | disclosed |
| US-3947488-A | O-Acylation using organothallium compounds | TAYLOR EDWARD C | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11345651-B2 | Addition condensation product, production method and use of same, polymerization vessel, and production method of polymer | MCCC2, PYCARD, PCCA | CYP2A6 2715/4885ALOX12 1760/4885ALDH1A1 2590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.